as on September 4, 2025 at 1:29 am IST
Day's Low
Day's High
0.92%
Downside
0.56%
Upside
52 Week's Low
52 Week's High
38.40%
Downside
1.20%
Upside
Check Incyte Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$17.0B
EPS (TTM)
6.1116
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.07%
PE Ratio (TTM)
20.56
Industry PE ratio
-130.36
P/B Ratio
20.5579
PEG Ratio
0.1297
EBITDA
1.1B
Revenue (TTM)
4.6B
Profit Margin
18.99%
Return On Equity TTM
24.30%
Track how Incyte Corporation P/E has moved over time to understand its valuation trends.
Incyte Corporation in the last 5 years
Lowest (12.11x)
June 30, 2025
Industry (-130.36x)
September 4, 2025
Today (20.56x)
September 4, 2025
Highest (67.12x)
September 30, 2024
Today’s Price to Earnings Ratio: 20.56x
Compare market cap, revenue, PE, and other key metrics of Incyte Corporation with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $17.0B | -3.9% | 20.56 | 18.99% | |
BUY | $58.6B | 264.27% | -505.15 | -12.96% | |
NA | $39.4B | NA | NA | -3.89% | |
BUY | $101.7B | NA | 28.25 | 31.86% | |
BUY | $59.8B | -2.85% | 14.21 | 31.37% |
The Incyte Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Incyte Corporation investment value today
Current value as on today
₹1,40,177
Returns
₹40,177
(+40.18%)
Returns from Incyte Corporation Stock
₹35,162 (+35.16%)
Dollar Returns*
₹5,014 (+5.01%)
Based on 29 analysts
55.17%
Buy
44.83%
Hold
0.00%
Sell
Based on 29 analysts, 55.17% of analysts recommend a 'BUY' rating for Incyte Corporation. Average target price of $81.7
Get share price movements and forecasts by analysts on Incyte Corporation.
What analysts predicted
-6.43%DOWNSIDE
Target Price
$81.7
Current Price
$86.95
Analyzed by
29 Analysts
Target
$81.70
Incyte Corporation target price $81.7, a slight downside of -6.43% compared to current price of $86.95. According to 29 analysts rating.
Search interest for Incyte Corporation Stock has increased by 66% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:66% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 22 August
Fri, 07:09 PM
-Eli Lilly and Incyte's Olumiant approved for rheumatoid arthritis and alopecia areata, generating $475.2 million in sales.
Fri, 09:38 PM
-Incyte updates clinical study on ruxolitinib for myelofibrosis, aiming to establish a safe starting dose.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, INCY stock has moved up by 3.9%
Profit Spike
Netprofit is up for the last 2 quarters, 158.20M → 404.99M (in $), with an average increase of 60.9% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, 1.05B → 1.21B (in $), with an average increase of 13.4% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 101.7% return, outperforming this stock by 77.9%
Against Peers
In the last 1 year, Beone Medicines Ltd has given 78.4% return, outperforming this stock by 43.2%
Organisation | Incyte Corporation |
Headquarters | 1801 Augustine Cut-Off, Wilmington, DE, United States, 19803 |
Industry | Health Technology |
CEO | Mr. Herve Hoppenot |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Herve Hoppenot | Advisor to CEO & Director |
Mr. Thomas Tray | VP of Finance, Chief Accounting Officer & Controller |
Ms. Sheila A. Denton J.D. | Executive VP, General Counsel & Corporate Secretary |
Ms. Pamela M. Murphy | Vice President of Investor Relations & Corporate Communications |
Mr. Michael James Morrissey | Executive VP & Head of Global Technical Operations |
Greg Shertzer | Senior Director of Investor Relations |
Dr. Pablo J. Cagnoni M.D., Ph.D. | President and Head of Research & Development |
Ms. Christiana Stamoulis M.B.A. | Executive VP & CFO |
Dr. Steven H. Stein M.D. | Executive VP & Chief Medical Officer |
Mr. William Meury | CEO, President & Director |
Incyte Corporation share price today is $86.95 as on at the close of the market. Incyte Corporation share today touched a day high of $87.44 and a low of $86.15.
Incyte Corporation share touched a 52 week high of $87.99 on and a 52 week low of $53.56 on . Incyte Corporation stock price today i.e. is closed at $86.95,which is 1.18% down from its 52 week high and 62.34% up from its 52 week low.
Incyte Corporation market capitalisation is $0.02T as on .
Indian investors can start investing in Incyte Corporation (INCY) shares with as little as ₹88.115 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.15 in Incyte Corporation stock (as per the Rupee-Dollar exchange rate as on ).
Based on Incyte Corporation share’s latest price of $86.95 as on September 4, 2025 at 1:29 am IST, you will get 0.1150 shares of Incyte Corporation. Learn more about
fractional shares .
Incyte Corporation stock has given -3.9% share price returns and 20.11% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?